Insights

Filters
clear all
Filters
Topics
Industry
Type
Brand
Auto Physical Damage Conference

CIECA Connex Conference 2024

Stakeholders across the collision industry are gathering at the Connex Conference to celebrate CIECA’s 30th anniversary and explore “The Intersection of Data &

Auto Physical Damage Conference

Rivian Certified Collision Network Summit 2024

As the first collision industry information provider to sign a data licensing agreement with Rivian, Mitchell is proud to be a Platinum Sponsor of the 2024 Certified Collision Network Summit.

Auto Physical Damage Article

Plugged-In: EV Collision Insights Q2 2024

August 15, 2024
4 MIN READ

Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) rose to 2.5% in the U.S. and 3.94% in Canada in Q2 2024—a year-over-year increase of 45% and 39% respectively. According to the Alliance for Automotive Innovation, EVs represented 9.3% of new U.S. light-duty vehicle sales in Q1 2024, down from 10.2% in Q4 2023. Similarly, in Canada BEV sales fell to 9.2% last quarter, down from 10% in Q4 2023.

Enlyte Article

Bridging the Gap for New Adjusters with Innovative Tools

August 13, 2024

Streamline your claims process and support your team with our cutting-edge solutions.

Auto Physical Damage Conference

SEMA 2024

The SEMA Show is the premier destination for manufacturers and buyers looking to discover thousands of the latest innovations in the automotive aftermarket industry.

Enlyte Podcast

New Trends in Opioids and Pain Management

August 7, 2024

Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.

Enlyte Article

Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation

August 6, 2024

Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.

MITCHELL

Technology and Expertise Driving Better Claims Outcomes

Mitchell simplifies and accelerates claims management and collision repair processes through the broadest range of technology solutions, networks, and partners in the P&C industry.

Learn More
GENEX

Helping Injured Workers Get Better, Faster.

Genex helps injured employees return to their jobs in a safe and efficient manner through compassionate case management while reducing total claim cost.

Learn More
NEWSLETTER

Sign up to Learn More